Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: International

Hartford International Opportunities HLS Fund

+ Add to Watchlist

HBIOX:US

15.51 USD 0.19 1.21%

As of 09:29:30 ET on 04/17/2015.

Snapshot for Hartford International Opportunities HLS Fund (HBIOX)

Year To Date: +8.54% 3-Month: +8.61% 3-Year: +10.66% 52-Week Range: 13.59 - 15.92
1-Month: +4.30% 1-Year: +5.92% 5-Year: +7.33% Beta vs GDUEACWZ: 0.96

Mutual Fund Chart for HBIOX

No chart data available.
  • HBIOX:US 15.51
  • 1M
  • 1Y
Interactive HBIOX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for HBIOX

Hartford International Opportunities HLS Fund is an open-end fund incorporated in the USA. The Fund seeks growth of capital. The Fund normally invests at least 65% of its assets in stocks issued by non-U.S. companies which trade in foreign markets that are generally considered to be well established. The Fund diversifies its investments among at least 3 countries other than the U.S.

Inception Date: 07-02-1990 Telephone: 1-800-862-6668
Managers: NICOLAS M CHOUMENKOVITCH
Web Site: www.invest.hartfordlife.com

Fundamentals for HBIOX

NAV (on 2015-04-17) 15.51
Assets (M) (on 2015-03-31) 1,471.18
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for HBIOX

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-08-27) 0.30
Dividend Yield (ttm) 1.91

Fees & Expenses for HBIOX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.68
Redemption Fee 0.00
12b1 Fee 0.25
Expense Ratio 0.98

Top Fund Holdings for HBIOX

Filing Date: 03/31/2015
Name Position Value % of Total
Novartis AG 516,025 52,775,992 3.532%
Anheuser-Busch InBev NV 410,790 52,112,827 3.488%
AstraZeneca PLC 599,631 41,322,857 2.766%
CRH PLC 1,182,094 33,371,891 2.234%
Sky PLC 2,022,335 31,048,216 2.078%
Taiwan Semiconductor Manufactu 6,458,035 30,811,786 2.062%
Deutsche Annington Immobilien 743,680 28,681,467 1.920%
WPP PLC 1,201,296 28,382,297 1.900%
UBS Group AG 1,583,399 27,819,723 1.862%
Snam SpA 5,308,086 26,863,507 1.798%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil